Insmed
INSM
#677
Rank
HK$274.34 B
Marketcap
HK$1,273
Share price
-1.47%
Change (1 day)
136.72%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -HK$9.32 Billion

According to Insmed's latest financial reports the company's current earnings are HK$0.60 Billion. a decrease over its 2024 earnings that were of -HK$6.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -HK$9.36 Billion43.91%
2024 -HK$6.51 Billion23.71%
2023 -HK$5.26 Billion45.77%
2022 -HK$3.61 Billion15.83%
2021 -HK$3.12 Billion50.19%
2020 -HK$2.08 Billion16.4%
2019 -HK$1.79 Billion-23.9%
2018 -HK$2.34 Billion59.35%
2017 -HK$1.47 Billion8.52%
2016 -HK$1.36 Billion47.25%
2015 -HK$0.92 Billion34.53%
2014 -HK$0.69 Billion58.83%
2013 -HK$0.44 Billion35.14%
2012 -HK$0.32 Billion-31.92%
2011 -HK$0.47 Billion854.92%
2010 -HK$48.96 Million-105.22%
2009 HK$0.93 B-905.06%
2008 -HK$0.12 Billion-27.31%
2007 -HK$0.17 Billion-62.41%
2006 -HK$0.43 Billion98.19%
2005 -HK$0.22 Billion0.03%
2004 -HK$0.22 Billion159.07%
2003 -HK$82.95 Million-69.31%
2002 -HK$0.28 Billion
2000 -HK$0.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$128.13 B-1,469.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$76.76 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$36.48 B-489.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-HK$1.98 Billion-78.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
HK$34.55 M-100.37%๐Ÿ‡บ๐Ÿ‡ธ USA